Thomas Jay Lowery
Chief Tech/Sci/R&D Officer en Satellite Biosciences, Inc. .
Perfil
Thomas Jay Lowery is currently the Chief Technology Officer at Satellite Biosciences, Inc. Previously, he worked as the Vice President-Diagnostics Research & Development at T2 Biosystems, Inc. He received his undergraduate degree from Brigham Young University and his doctorate from the University of California, Berkeley.
Cargos activos de Thomas Jay Lowery
Empresas | Cargo | Inicio |
---|---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
Antiguos cargos conocidos de Thomas Jay Lowery.
Empresas | Cargo | Fin |
---|---|---|
T2 BIOSYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Thomas Jay Lowery.
Brigham Young University | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
T2 BIOSYSTEMS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Jay Lowery